| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_758994071efb42b565fc2c04637be131 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08 |
| filingDate |
2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_870852d71be02fe3038585e2927efc87 |
| publicationDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014091980-A1 |
| titleOfInvention |
Hyaluronic acid composition |
| abstract |
The purpose of the present invention is to provide a hyaluronic acid composition which contains a component having health risks as little as possible.nThe hyaluronic acid composition according to the present invention is a hyaluronic acid composition containing hyaluronic acid (A), fulfills the requirement represented by item (1) mentioned below, and has a ratio of the weight of a hyaluronic acid synthase (B) to the weight of the hyaluronic acid (A) (hyaluronic acid synthase (B)/hyaluronic acid (A)) in the hyaluronic acid composition of 1/100 or less: (1) the total amount of N-acetylgalactosamine and galactosamine in constituent monosaccharides that constitute the hyaluronic acid (A) contained in the hyaluronic acid composition is 5 wt% or less relative to the weight of the hyaluronic acid (A). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108883047-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017025157-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108883047-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017178415-A1 |
| priorityDate |
2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |